;PMID: 2538792
;source_file_803.mrg
;Release 0.9 of PennBioIE
;Funded by NSF ITR EIA-0205448

;0)section:[e:0..30] = [t:0..30]
;1)sentence:[e:35..140] = [t:35..140]
;2)section:[e:144..162] = [t:144..162]
;3)section:[e:166..226] = [t:166..226]
;4)sentence:[e:230..444] = [t:230..444]
;5)sentence:[e:445..677] = [t:445..677]
;6)sentence:[e:678..764] = [t:678..764]
;7)sentence:[e:765..918] = [t:765..918]
;8)section:[e:922..966] = [t:922..966]

;section 0 Span:0..30
;Oncogene  1989 Feb;4(2):189-93
(SEC
  (FRAG (IN:[0..8] Oncogene) (CD:[10..14] 1989) (CC:[15..21] Feb;4-LRB-)
        (CD:[21..22] 2) (-RRB-:[22..23] -RRB-) (CD:[23..27] :189) (::[27..28] -)
        (CD:[28..30] 93)))

;sentence 1 Span:35..140
;Activated N-ras gene was found in human hepatoma tissue but only in a small 
;fraction of the tumor cells.
;[45..50]:gene-rna:"N-ras"
;[75..90]:malignancy:"hepatoma tissue"
;[128..139]:malignancy:"tumor cells"
(SENT
  (S-HLN
    (NP-SBJ-1 (JJ:[35..44] Activated) (NN:[45..50] N-ras) (NN:[51..55] gene))
    (VP (VBD:[56..59] was)
      (VP
        (VP (VBN:[60..65] found)
          (NP-1 (-NONE-:[65..65] *))
          (PP-LOC=2 (IN:[66..68] in)
            (NP (JJ:[69..74] human)
               (NN:[75..83] hepatoma) (NN:[84..90] tissue))))
        (CC:[91..94] but)
        (VP
          (ADVP (RB:[95..99] only))
          (PP-LOC=2 (IN:[100..102] in)
            (NP
              (NP (DT:[103..104] a) (JJ:[105..110] small)
                  (NN:[112..120] fraction))
              (PP (IN:[121..123] of)
                (NP (DT:[124..127] the)
                   (NN:[128..133] tumor) (NNS:[134..139] cells))))))))
    (.:[139..140] .)))

;section 2 Span:144..162
;Takada S, Koike K.
(SEC
  (FRAG (NNP:[144..150] Takada) (NNP:[151..153] S,) (NNP:[154..159] Koike)
        (NNP:[160..162] K.)))

;section 3 Span:166..226
;Department of Gene Research, Cancer Institute, Tokyo, Japan.
(SEC
  (FRAG (NNP:[166..176] Department) (IN:[177..179] of) (NNP:[180..184] Gene)
        (NNP:[185..193] Research) (,:[193..194] ,) (NNP:[195..201] Cancer)
        (NNP:[202..211] Institute) (,:[211..212] ,) (NNP:[213..218] Tokyo)
        (,:[218..219] ,) (NNP:[220..225] Japan) (.:[225..226] .)))

;sentence 4 Span:230..444
;Activated N-ras gene was isolated from human hepatoma tissue by DNA
;transfection  assay coupled with the neomycin selection method and molecular
;cloning and a  point mutation in the codon 61 (CAA----AAA) was noted.
;[240..245]:gene-rna:"N-ras"
;[275..290]:malignancy:"hepatoma tissue"
;[390..404]:variation-type:"point mutation"
;[412..420]:variation-location:"codon 61"
;[422..425]:variation-state-original:"CAA"
;[429..432]:variation-state-altered:"AAA"
(SENT
  (S
    (S
      (NP-SBJ-1 (JJ:[230..239] Activated) (NN:[240..245] N-ras)
                (NN:[246..250] gene))
      (VP (VBD:[251..254] was)
        (VP (VBN:[255..263] isolated)
          (NP-1 (-NONE-:[263..263] *))
          (PP (IN:[264..268] from)
            (NP (JJ:[269..274] human)
               (NN:[275..283] hepatoma) (NN:[284..290] tissue)))
          (PP-MNR (IN:[291..293] by)
            (NP
              (NP (NN:[294..297] DNA) (NN:[298..310] transfection)
                  (NN:[312..317] assay))
              (VP (VBN:[318..325] coupled)
                (NP (-NONE-:[325..325] *))
                (PP-CLR (IN:[326..330] with)
                  (NP (DT:[331..334] the) (NN:[335..343] neomycin)
                      (NN:[344..353] selection) (NN:[354..360] method)))))))))
    (CC:[361..364] and)
    (S
      (NP-SBJ-2
        (NP
          (NP (JJ:[365..374] molecular) (NN:[375..382] cloning))
          (CC:[383..386] and)
          (NP (DT:[387..388] a)
             (NN:[390..395] point) (NN:[396..404] mutation)))
        (PP-LOC (IN:[405..407] in)
          (NP (DT:[408..411] the)
             (NN:[412..417] codon) (CD:[418..420] 61)
            (PRN (-LRB-:[421..422] -LRB-)
              (NP
                (NP (NN:[422..425] CAA))
                (PP (SYM:[425..429] ----)
                  (NP (NN:[429..432] AAA))))
              (-RRB-:[432..433] -RRB-)))))
      (VP (VBD:[434..437] was)
        (VP (VBN:[438..443] noted)
          (NP-2 (-NONE-:[443..443] *)))))
    (.:[443..444] .)))

;sentence 5 Span:445..677
;However, examination of  the proportion of the mutated N-ras gene in the
;tumor part by molecular cloning  and by hybridization using synthetic
;oligonucleotide probes indicated that the  mutated gene occurred with very
;low frequency.
;[500..505]:gene-rna:"N-ras"
;[518..523]:malignancy:"tumor"
;[639..643]:gene-rna:"gene"
(SENT
  (S
    (ADVP (RB:[445..452] However))
    (,:[452..453] ,)
    (NP-SBJ
      (NP (NN:[454..465] examination))
      (PP (IN:[466..468] of)
        (NP
          (NP (DT:[470..473] the) (NN:[474..484] proportion))
          (PP (IN:[485..487] of)
            (NP (DT:[488..491] the) (JJ:[492..499] mutated)
                (NN:[500..505] N-ras) (NN:[506..510] gene)))))
      (PP (IN:[511..513] in)
        (NP (DT:[514..517] the) (NN:[518..523] tumor) (NN:[524..528] part)))
      (PP-MNR
        (PP (IN:[529..531] by)
          (NP (JJ:[532..541] molecular) (NN:[542..549] cloning)))
        (CC:[551..554] and)
        (PP (IN:[555..557] by)
          (NP
            (NP (NN:[558..571] hybridization))
            (VP (VBG:[572..577] using)
              (NP (JJ:[578..587] synthetic) (NN:[588..603] oligonucleotide)
                  (NNS:[604..610] probes)))))))
    (VP (VBD:[611..620] indicated)
      (SBAR (IN:[621..625] that)
        (S
          (NP-SBJ (DT:[626..629] the) (JJ:[631..638] mutated)
                  (NN:[639..643] gene))
          (VP (VBD:[644..652] occurred)
            (PP (IN:[653..657] with)
              (NP
                (ADJP (RB:[658..662] very) (JJ:[663..666] low))
                (NN:[667..676] frequency)))))))
    (.:[676..677] .)))

;sentence 6 Span:678..764
;The activated N-ras gene appears  located only in a small fraction of the
;tumor cells.
;[692..697]:gene-rna:"N-ras"
;[752..763]:malignancy:"tumor cells"
(SENT
  (S
    (NP-SBJ (DT:[678..681] The) (JJ:[682..691] activated) (NN:[692..697] N-ras)
            (NN:[698..702] gene))
    (VP (VBZ:[703..710] appears)
      (S
        (NP-SBJ (-NONE-:[710..710] *))
        (VP (VBN:[712..719] located)
          (NP (-NONE-:[719..719] *))
          (PP-LOC
            (ADVP (RB:[720..724] only))
            (IN:[725..727] in)
            (NP
              (NP (DT:[728..729] a) (JJ:[730..735] small)
                  (NN:[736..744] fraction))
              (PP (IN:[745..747] of)
                (NP (DT:[748..751] the)
                   (NN:[752..757] tumor) (NNS:[758..763] cells))))))))
    (.:[763..764] .)))

;sentence 7 Span:765..918
;The experimental data  indicate activation of this gene as possibly not the
;major cause of carcinoma,  but rather a manifestation of tumor
;heterogeneity.
;[816..820]:gene-rna:"gene"
;[856..865]:malignancy:"carcinoma"
(SENT
  (S
    (NP-SBJ (DT:[765..768] The) (JJ:[769..781] experimental)
            (NNS:[782..786] data))
    (VP (VBP:[788..796] indicate)
      (NP
        (NP (NN:[797..807] activation))
        (PP (IN:[808..810] of)
          (NP (DT:[811..815] this) (NN:[816..820] gene))))
      (PP (IN:[821..823] as)
        (NP
          (NP
            (NP
              (ADVP (RB:[824..832] possibly) (RB:[833..836] not))
              (DT:[837..840] the) (JJ:[841..846] major) (NN:[847..852] cause))
            (PP (IN:[853..855] of)
              (NP (NN:[856..865] carcinoma))))
          (,:[865..866] ,)
          (CONJP (CC:[868..871] but) (RB:[872..878] rather))
          (NP
            (NP (DT:[879..880] a) (NN:[881..894] manifestation))
            (PP (IN:[895..897] of)
              (NP (NN:[898..903] tumor) (NN:[904..917] heterogeneity)))))))
    (.:[917..918] .)))

;section 8 Span:922..966
;PMID: 2538792 [PubMed - indexed for MEDLINE]
(SEC
  (FRAG (NNP:[922..926] PMID) (::[926..927] :) (CD:[928..935] 2538792)
        (NN:[936..937] -LSB-) (NNP:[937..943] PubMed) (::[944..945] -)
        (NN:[946..953] indexed) (IN:[954..957] for)
        (NNP:[958..966] MEDLINE-RSB-)))
